Dalteparin (Fragmin vial) is an anticoagulant (blood thinner) that prevents blood clots in persons undergoing surgery. Along with aspirin Dalteparin (Fragmin vial) is prescribed for heart attack, ...

Pfizer won the backing of a US Food and Drug Administration advisory panel yesterday to extend the use of its anti-clotting drug Fragmin to include the prevention of venous thromboembolism (VTE) in ...

The approval of the drug Fragmin, an anti-coagulant subcutaneous use, will seek to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients—which can include deep vein ...

The drug was initially approved by the FDA in 1994 for adults and is a type of heparin. The US Food and Drug Administration has approved Pfizer’s Fragmin (dalteparin sodium) injection to reduce the ...

The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in pediatric patients 1 month of age and older.

FDA Approves Pfizer's and Eisai's FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer WOODCLIFF LAKE, N.J. and NEW ...

Dalteparin injectable solution is available as a brand-name drug only. It’s not available as a generic drug. Brand name: Fragmin. Dalteparin comes only in the form of an injectable solution. It’s ...

The US Food and Drug Administration (FDA) approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in paediatric ...

Patients aged over 18 years with WHO performance status 0–2 and histologically proven advanced malignancy refractory to conventional treatment who gave written informed consent were eligible for the ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Dalteparin (Fragmin vial) is an anticoagulant ...